13th International Conference of the Society of Integrative Oncology

The following five abstracts were chosen as the best submitted studies presented at this year’s International Conference of the Society for Integrative Oncology (SIO). They represent a diverse group o...

Integrative Oncology

Jo Cavallo / December 25, 2016 / 13th International Conference of the Society of Integrative Oncology

Advancing the Global Impact of Integrative Oncology

The 13th International Conference of the Society of Integrative Oncology (SIO) held in Miami, Florida, in November, drew its largest audience yet, with nearly 400 clinicians, researchers, patients, a...

Sep

Today In Oncology

2018 Quality Care: Opioid Deaths Are 10 Times Less Likely to Occur in Patients With Cancer Compared to the General Population

2018 Quality Care: Older Patients With Advanced Cancer Experiencing Financial Difficulties Have Worse Quality of Life and Mental Health

2018 Quality Care: Nationwide Survey Reveals Patients With Metastatic Breast Cancer Face Major Financial Stress Due to Treatment Costs

2018 Quality Care: Few Women With Breast Cancer Discuss Costs With Physicians Before Beginning Treatment

2018 Quality Care: New Approach Successfully Reduces Opioid Use After Urologic Oncology Surgery

;

13th International Conference of the Society of Integrative Oncology

The Best of SIO

Advancing the Global Impact of Integrative Oncology

2018 Quality Care: Opioid Deaths Are 10 Times Less Likely to Occur in Patients With Cancer Compared to the General Population

2018 Quality Care: Older Patients With Advanced Cancer Experiencing Financial Difficulties Have Worse Quality of Life and Mental Health

2018 Quality Care: Nationwide Survey Reveals Patients With Metastatic Breast Cancer Face Major Financial Stress Due to Treatment Costs

2018 Quality Care: Few Women With Breast Cancer Discuss Costs With Physicians Before Beginning Treatment

2018 Quality Care: New Approach Successfully Reduces Opioid Use After Urologic Oncology Surgery

2018 ASCO: Adjuvant mFOLFIRINOX vs Gemcitabine in Resected Pancreatic Cancer

First-Line Nab-Paclitaxel and Gemcitabine in Advanced Cholangiocarcinoma

Pertuzumab and Trastuzumab Plus Chemotherapy in HER2-Positive, Metastatic Gastric or Gastroesophageal Junction Cancer

Researchers Identify Pitfall in PSMA PET Imaging Method

FDA Accepts sBLA for Pembrolizumab Monotherapy in First-Line Treatment of Locally Advanced or Metastatic PD-L1–Expressing NSCLC

Eric Jonasch, MD, on Kidney Cancer: Current and Novel Treatment Options

Bernard J. Escudier, MD, on RCC: Results From the IMmotion151 Trial

Apostolia-Maria Tsimberidou, MD, PhD, on Precision Medicine: Results From the IMPACT Study

Limo Chen, PhD, on Lung Cancer and CD38: Resistance to Immunotherapy

Michael Gnant, MD, on Breast Cancer: Results From the ABCSG-18 Trial